In-house IP roundup: USPTO eligibility guidance could create consistency; advice and anecdotes on protecting IP in China
Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses
1. Tech and life sciences: USPTO eligibility guidance could create consistency
Barclays, Regeneron, Amadeus and others say the new guidance on Section 101-related subject matter could lead to more reliable patent examinations – and may mark the start of a post-Alice framework reversal.
2. Advice and anecdotes on protecting IP in China
At Managing IP’s International Patent Forum in London in March, panellists gave colourful examples of how foreign companies can go about protecting their IP in China.
3. How businesses choose between trade secrets and patents
In-house counsel say that deciding between a trade secret and a patent requires looking at patentability, potential infringement detection, and whether an invention could realistically be kept under wraps.
Sign up to receive more content like this in Patent Strategy’s weekly newsletter.